Non-Tariff Barriers

Non-Tariff Measure

NTM classification

B7: Product quality, safety or performance requirements 

Date when the measure came into force

01 January 1985 

Publication where the measure is specified

Proclamation No. 24 of 1984 

Regulation where the measure is specified

The Pharmacy Act 1983 

Country/Region applying the measure

Mauritius 

The rationale of the measure

None specified 

Coded list of objectives

X: For purposes n.e.s. 

Description of the measure

31 Standards of therapeutic substances
(1) Subject to section 32, no person shall manufacture or sell a therapeutic substance specified in the Sixth Schedule unless it conforms to the specified standards.
(2) The Permanent Secretary may order the forfeiture of any therapeutic substance which does not comply with subsection (1). 

Reference of the measure

Article 31 

Measure also domestic

Yes 

Notes

Specific quality standard requirements not given 

Products affected by the measure.

Description

Vaccines, sera; toxins, antitoxins and antigens
Amikacin; its salts
Amphomycin; its salts, its esters; their salts
Amphotericins; their salts
Arsphenamine and analogue substances used for the specific treatment of infective disease
Bacitracin
Campreomycin; its salts; its esters; their salts
Cephalosporins; their salts; their esters; their salts; esters of such salts
Cephamycins
Chloramphenicol; its esters
Chlortetracycline
Clindamycin; its salts; its esters
Colistin; its salts; its esters
Corticotrophin (Adrenocorticotrophichormone, ACTH)
Cortisone; its esters
Cycloserine; its salts
Dimethylchlortetracycl me; its salts
Erythromycin; its esters
Framycetin; its salts
Fusidic acid; its salts; its esters; their salts
Gentamicin; its salts; its esters; their salts
Griseofulvin, its salts
Hydrocortisone; its esters
Isoniazid; its salts; its derivatives; their salts
Kanamycin; its salts
Lincomycins —
S-alkyl derivatives of 6, 8-dedeoxy-6-trans- (4-alyky-L-2-pyrol idi ne-carboxamido)--I-thio-Derythro-
&-D-galacto-octo-pyranoside N-pyrollidine analogues thereof; their esters; their
salts
Nalidixic acid; its salts; its esters; their salts
Neomycin; its salts
Novobiocin; its salts
Nystatin; its salts
Oleandomycin; its salts; its esters; their salts
Organic substances having the specific biological action of curare on neuro-muscular
transmission; preparation of such substances
Oxytetracycline; its salts
Para-aminosalicylic acid; its salts
Paramomyclin; its salts; its esters; their salts
Penicillins; their salts; their derivatives; their esters
Polymyxins; their salts
Prednisolone; its esters
Prednisone; its esters
Preparations of the specific antidiabetic principle of the pancreas known as insulin
Preparations of the posterior lobe of the pituitary body
Preparations of human blood
Rifamycins —
A group of related macrolactams, either produced by the growth of Streptomyces
mediterranei or by
modification of such products, and containing the chemical structure of 11, -acetoxy-7, 9,
15-trihydroxymethoxy-2, 6, 8, 10, 1 2-pentamethyl pentadeca-2, 4, 1 4-trienoic acid amide,
attached by the nitrogen atom and by the oxygen atom in the 15-position respectively to the
7and 2-position of a 5, 6, 9-tn-oxygenated 2, 4-dimethyl-1 -oxonaphtho (2, 1-b) furan; their
salts and esters
Salts of their esters
Ristocetins; their salts
Spectinomycin; its salts
Spiramycin; its salts
Streptomycin; its salts, its derivatives and salts of such derivatives
Tobramycin, its salts
Tetracyclines —
Antimicrobial substances containing the chemical structure — naphthacene-2-carboxymide,
hydrogenated to any extent, and having each of the position 1, 3, 10, 14 and 12 substituted
by a hydroxyl or an oxogroup; their salts
Vancomycin; its salts
Viomycin; its salts
Virginiamycin; its salts 

Countries/Regions affected by the measure.

Description

Entire world